@article{60a08620419e4d739e8424539f2986f0,
title = "Preinfection glycaemic control and disease severity among patients with type 2 diabetes and COVID-19: A retrospective, cohort study",
author = "Samah Hayek and Yatir Ben-Shlomo and Ran Balicer and Katherine Byrne and Mark Katz and Eldad Kepten and Itamar Raz and Eytan Roitman and Marcin Zychma and Noam Barda",
note = "Funding Information: SH, YB‐S, RB, MK, EK, ER and NB are employees of the Clalit Research Institute, which received funding from Novo Nordisk. KB and MZ are Novo Nordisk employees. IR received personal fees from Novo Nordisk. Funding Information: The authors acknowledge the medical writing assistance of Caroline Freeman and Nicolas Bertheleme of Oxford PharmaGenesis Ltd, Oxford, UK. The medical writing agency was funded by Novo Nordisk International Operations. Novo Nordisk International Operations funded the study and participated in the conception of the design. ",
year = "2021",
month = aug,
day = "1",
doi = "10.1111/dom.14393",
language = "English",
volume = "23",
pages = "1995--2000",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "8",
}
